Results 51 to 60 of about 5,941 (179)

Trail Toward Tenecteplase

Annals of Indian Academy of Neurology, 2022
Trilochan Srivastava, Neetu Ramrakhiani, Vikram Bohra   +2 more
openaire   +3 more sources

Uso de trombolíticos e associações farmacológicas no tratamento do acidente vascular cerebral isquêmico agudo : revisão sistemática e meta-análise em rede [PDF]

, 2017
Dissertação (mestrado)—Universidade de Brasília, Faculdade de Ciências da Saúde, Programa de Pós-Graduação em Ciências da Saúde, 2017.Introdução: O acidente vascular cerebral isquêmico (AVCi) é uma das principais causas de mortalidade e incapacidade ...
Brito, Gabriela Vilela de
core  

Estudo da associação entre a ativação da resposta inflamatória sistêmica na fase aguda do infarto do miocárdio com supradesnivelamento do segmento ST e a zona peri-infarto, definida por ressonância magnética [PDF]

, 2013
Tese (doutorado)—Universidade de Brasília, Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, 2013.Introdução: O aumento da atividade inflamatória sistêmica (AIS) durante o infarto domiocárdio (IM) está diretamente associado à ...
Silva, José Carlos Quinaglia e
core  

Initial experience with the left ventricular assist device TransCoreTM [PDF]

, 2010
Cardiogenic shock is a condition associated to high mortality rates. For decades, the treatment consisted of vasoactive drugs and intra-aortic balloon pump.
Alves, Claudia Maria Rodrigues, Lima, Valter Correia De, Minohara, Stéfano Franco, Souza, Cristiano Freitas De   +3 more
core   +1 more source

Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke

Scientific Reports
To evaluate the safety and efficacy of dual antiplatelet therapy (DAPT) versus tenecteplase in minor non-disabling acute ischemic stroke. This retrospective observational study utilized data from our stroke database.
Xinzhao Jiang, Ruozhen Yuan, Jiawei Ye, Xu Wang, Zongjie Shi, Shunyuan Guo   +5 more
doaj   +1 more source

Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial

Stroke and Vascular Neurology
Background The benefit of intravenous alteplase in acute ischaemic stroke (AIS) is time-dependent. Tenecteplase is non-inferior to alteplase among patients with AIS.
Bruce C V Campbell, Yongjun Wang, Yilong Wang, Zixiao Li, Xingquan Zhao, David Wang, Yunyun Xiong, Hao Li, Xia Meng, Yuesong Pan, Lee H Schwamm, Aoming Jin, Mark W Parsons, Huaguang Zheng, Shuya Li, Runhui Li, Marc Fisher, Runqi Wangqin, Ziran Wang, Deyang Li, Hongguo Dai, Junhai Wang   +21 more
doaj   +1 more source

Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4) [PDF]

, 2012
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are largely employed for treating patients with left ventricular dysfunction (LVD), but their efficacy may be negatively affected by concomitant administration of acetylsalicylic acid (ASA),
Claudio Borghi, Dragos Vinereanu, Ettore Ambrosioni, Giuseppe Ambrosio, null null, Salvatore Novo   +5 more
core   +1 more source

Tenecteplase: biochemical and clot lysis activity comparisons

Frontiers in Pharmacology
IntroductionIn the last decades, the recombinant tissue plasminogen activator alteplase has been the standard fibrinolytic treatment of acute myocardial infarction, pulmonary embolism, and acute ischemic stroke.
Jan Bechmann, Ira Schmid, Simone Brand, Felix Miller, Chengzhi Zhang   +4 more
doaj   +1 more source

A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Time to Pass the Torch

Stroke: Vascular and Interventional Neurology
Alteplase, a biosynthetic form of human tissue‐type plasminogen activator, is Food and Drug Administration‐approved for the treatment of acute ischemic stroke and currently the standard of care for thrombolytic therapy.
Miguel Rodriguez, Christian Sidebottom, Drew A. Wells, Thirumalaivasan Dhasakeerthi, Lisa Hayes, Cheran Elangovan, Balaji Krishnaiah   +6 more
doaj   +1 more source

Reduction of Steroid-Induced Intraocular Pressure Elevation in Sheep by Tissue Plasminogen Activator [PDF]

, 2013
PURPOSE. To investigate whether tissue plasminogen activator (tPA) can prevent and/or reverse steroid-induced IOP elevation in an ovine model. METHODS.
Alvarez, Larry, Candia, Oscar, Danias, John, Gerometta, Rosana María del Rosario, Kumar, Sandeep, Shah, Shaily   +5 more
core   +2 more sources